Literature DB >> 22706121

Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?

Dorota Smolarek1, Olivier Bertrand, Marcin Czerwinski.   

Abstract

Serum of animals belonging to the Camelidae family (camels and llamas) contains fully active antibodies that are naturally devoid of light chains. Variable domains derived from heavy chain antibodies (hcAb) called VHHs or nanobodies™ can bind antigens as effectively as full-length antibodies and are easy to clone and express. Because of their potential, VHHs are being intensively studied as potential therapeutic, diagnostic and imaging tools. The paper reviews the molecular background of heavy chain antibodies and describes methods of obtaining recombinant fragments of heavy chain antibodies as well as their therapeutic, diagnostic and other applications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706121     DOI: 10.5604/17322693.1000334

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  11 in total

1.  Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Authors:  Andrew W Woodham; Ross W Cheloha; Jingjing Ling; Mohammad Rashidian; Stephen C Kolifrath; Maia Mesyngier; Joao N Duarte; Justin M Bader; Joseph G Skeate; Diane M Da Silva; W Martin Kast; Hidde L Ploegh
Journal:  Cancer Immunol Res       Date:  2018-05-23       Impact factor: 11.151

2.  Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target.

Authors:  Seyed Khalil Rashidi; Seyed Latif Mousavi Gargari; Walead Ebrahimizadeh
Journal:  Iran J Biotechnol       Date:  2017-08-19       Impact factor: 1.671

3.  A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.

Authors:  Davide Ferrari; Valentina Garrapa; Massimo Locatelli; Angelo Bolchi
Journal:  Mol Biotechnol       Date:  2020-01       Impact factor: 2.695

Review 4.  VHH antibodies: emerging reagents for the analysis of environmental chemicals.

Authors:  Candace S Bever; Jie-Xian Dong; Natalia Vasylieva; Bogdan Barnych; Yongliang Cui; Zhen-Lin Xu; Bruce D Hammock; Shirley J Gee
Journal:  Anal Bioanal Chem       Date:  2016-05-21       Impact factor: 4.142

5.  Antiviral activity of a single-domain antibody immunotoxin binding to glycoprotein D of herpes simplex virus 2.

Authors:  Eileen M Geoghegan; Hong Zhang; Prashant J Desai; Arya Biragyn; Richard B Markham
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.938

6.  Noninvasive imaging of immune responses.

Authors:  Mohammad Rashidian; Edmund J Keliher; Angelina M Bilate; Joao N Duarte; Gregory R Wojtkiewicz; Johanne Tracey Jacobsen; Juanjo Cragnolini; Lee Kim Swee; Gabriel D Victora; Ralph Weissleder; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

Review 7.  Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19).

Authors:  Salma Bessalah; Samira Jebahi; Naceur Mejri; Imed Salhi; Touhami Khorchani; Mohamed Hammadi
Journal:  3 Biotech       Date:  2021-01-22       Impact factor: 2.406

8.  Noninvasive Immuno-PET Imaging of CD8+ T Cell Behavior in Influenza A Virus-Infected Mice.

Authors:  Paul W Rothlauf; Zeyang Li; Novalia Pishesha; Yushu Joy Xie; Andrew W Woodham; Djenet Bousbaine; Stephen C Kolifrath; Vincent L Verschoor; Hidde L Ploegh
Journal:  Front Immunol       Date:  2021-11-03       Impact factor: 7.561

Review 9.  Nanobody: the "magic bullet" for molecular imaging?

Authors:  Rubel Chakravarty; Shreya Goel; Weibo Cai
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556

10.  Blocking of Histamine Release and IgE Binding to FcεRI on Human Basophils by Antibodies Produced in Camels.

Authors:  Al Qaoud Khaled; Yousef Sana; Rawashdeh Abdulrahman; Khalil Raida; Abdel Hafez Sami
Journal:  Allergy Asthma Immunol Res       Date:  2015-06-25       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.